32361-76-5

Basic information

• Product Name: Pyridine, 3-[(4-nitrophenyl)methyl]-
• CAS NO: 32361-76-5
• Molecular Formula: C12H10N2O2
• Molecular Weight: 214.224
• Mol File: 32361-76-5.mol
• Article Data: 12

Chemical Properties

• CAS DataBase Reference: Pyridine, 3-[(4-nitrophenyl)methyl]-(CAS DataBase Reference)
• NIST Chemistry Reference: Pyridine, 3-[(4-nitrophenyl)methyl]-(32361-76-5)
• EPA Substance Registry System: Pyridine, 3-[(4-nitrophenyl)methyl]-(32361-76-5)

Safety Data

• Hazardous Substances Data: 32361-76-5(Hazardous Substances Data)

Upstream product

• 620-95-1 3-benzylpyridine 

Downstream Products

• 85666-15-5 4-(3'-Pyridinylmethyl)aniline 
• 178809-75-1 4-(1-hydroxy-1-(4-pyridyl)methyl)-1-nitrobenzene 
• 85666-17-7 furegrelate sodium 
• 85666-43-9 3-bromo-2-hydroxy-5-(3-pyridylmethyl)benzaldehyde 
• 85666-04-2 3-(3-formyl-4-hydroxybenzyl)pyridine 
• 75987-20-1 3-(4'-Hydroxybenzyl)pyridine 
• 110141-52-1 (4-nitro-phenyl)-[3]pyridyl ketone 
• 62-23-7 4-nitro-benzoic acid 

Relevant articles and documents

INHIBITION OF P38 KINASE ACTIVITY USING SUBSTITUTED HETEROCYCLIC UREAS

This invention relates to the use of a group of aryl ureas in treating cytokine mediated diseases, other than cancer and proteolytic enzyme mediated diseases, other than cancer, and pharmaceutical compositions for use in such therapy.

Inhibition Of Raf Kinase Using Symmetrical And Unsymmetrical Substituted Diphenyl Ureas

This invention relates to the use of a group of aryl ureas in treating raf mediated diseases, and pharmaceutical compositions for use in such therapy.

INHIBITION OF p38 KINASE USING SYMMETRICAL AND UNSYMMETRICAL DIPHENYL UREAS

This invention relates to the use of a group of aryl ureas in treating cytokine mediated diseases and proteolytic enzyme mediated diseases, and pharmaceutical compositions for use in such therapy.